# Adolescent Fibromyalgia Study

> **NCT01020474** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 107 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** placebo
- **DRUG:** pregabalin (Lyrica)

## Key facts

- **NCT ID:** NCT01020474
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020474, "Adolescent Fibromyalgia Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01020474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*